FLT4 Antikörper (C-Term) (APC)
Kurzübersicht für FLT4 Antikörper (C-Term) (APC) (ABIN1896125)
Target
Alle FLT4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Aufreinigung
- Protein G purified
-
Immunogen
-
KLH conjugated synthetic peptide selected from the C-terminal region of human FLT4.
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: ELISA, IHC
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, no preservatives added
-
Konservierungsmittel
- Without preservative
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
-
Haltbarkeit
- 6 months
-
-
- FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))
-
Andere Bezeichnung
- FLT4 / VEGFR3
-
Hintergrund
-
Name/Gene ID: FLT4
Subfamily: VEGF Receptor
Family: Protein Kinase
Synonyms: FLT4, FLT41, Fms-related tyrosine kinase 4, Fms-like tyrosine kinase 4, LMPH1A, PCL, Soluble VEGFR3 variant 1, Vegf-r3, VEGFR3, Soluble VEGFR3 variant 2, Soluble VEGFR3 variant 3, FLT-4, Quek2, VEGF Receptor 3, VEGFR-3 -
Gen-ID
- 2324
-
Pathways
- RTK Signalweg, Signaling Events mediated by VEGFR1 and VEGFR2, VEGF Signaling
Target
-